सभी उपयोगकर्ता पोस्ट Diksha Pote . पुणे , भारत

Kidney Stone Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2027


Key Players:

The key players profiled in Kidney stone are Boston Scientific Corporation, Convergent Laser Technologies, DirexGroup, Siemens Healthcare GmbH, C.R. Bard Inc, Cook Medical Inc., Dornier MedTech GmbH, Richard Wolf Medical Instruments Corporation, Olympus Corporation, and Stryker Corporation

Global Kidney stones Market – Overview

Kidney stones are hard mineral deposits inside the kidneys that can cause severe pain and discomfort. The global kidney stone market is growing at a steady pace and it is expected to grow at a CAGR of 4.0% during the forecast period of 2017 - 2022. There are a number of protuberant factors associated with this Global Kidney Stone Market Report. Growing demand for minimally invasive procedures driven by the surging preference of these is one of the major drivers contributing to the market growth. The preference to minimally invasive procedures is driven by their success rate which is 75-100%. Additionally, according to the National Kidney Foundation, it has been found that more than 73 million adults have high blood pressure and 29 million adults are suffering from diabetes which are the major reason for urolithiasis. That being said, continuously recorded and increasing instances of urolithiasis in the adult is leading to the rise in the prevalence of kidney stone disorder across the globe. Another major reason driving the prevalence of how much is a kidney stone worth is population and poor nutrition. According to experts, individuals who are predisposed to hunger and sub-par nutrition are prone to kidney disorders and thus, add to the total global prevalence to a great extent. With such growth factors the market size is expected to reach $3,000 million in 2022 from $2,277.4 in 2016.

Global Kidney stones Market - Competitive Analysis

Globally there are various players operating in this market. With well-established market in the North America region major companies have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other regions as well. Moreover there are other small and medium scale players that generate revenue from local market.

Minimally invasive procedures for the treatment of kidney stones has been the major factor influencing the growth of the market. A majority of industrial competitors involved in this market have been keen on introducing advanced products for minimally invasive procedures. In November 2016, Boston Scientific Corporation introduced Dakota Nitinol Stone Retrieval Device with OpenSure Handle in US and Europe market. This kidney stone retrieval device is designed to allow to release and capture kidney stones of multiple sizes from complex stones as large as 10 millimeters to fragments as small as one millimeter. This product will support the company to imprison its position and resolve a few challenges faced during ureteroscopy procedures. Adding to this in May 2017, Lumenis a well know medical device company launched its New Moses holmium technology in the American Urological Association Annual Meeting. To this technology Dr. Andrew Symes, Consultant Urological Surgeon said “The Moses technology provides a greater sense of control due to minimized retropulsion. This is particularly valuable when dusting large stones in the kidney, but also when dealing with upper ureteric stones”. These advancements are collectively influencing the growth of this market positively.

Furthermore the kidney stone treatment market has turned into a critical factor in the global urology industry. Through extensive research it is found out that the market players have adopted the strategy of acquisitions in the market. In 2016 Boston Scientific acquired Distal Access, LLC with its product line gynecology and urology. Distal Access a U.S. based company involved in manufacturing minimal invasive devices. This acquisition will help Boston Scientific reduce the pressure of developing minimal invasive devices. The gynecology and urology devices manufactured by Distal Access will be integrated into the Boston Scientific urology and pelvic health business. Be that as it may, in February 2016, Stryker Corp announced a definitive agreement to acquire Synergetics USA, Inc.'s Neuro Portfolio. This strategic step of the company to acquire all the neurological product portfolio of Synergetics USA, Inc.'s will strengthen the company’s presence in the field of Neurology, adding to their global footprint. In a similar distribution agreement by the Olympus Corp of The Americas with Arc Medical Design, will facilitate and improve the distribution strength of the partner companies in the U.S. and Canada, resulting in improving their worldwide sales. There are various others players involved in following this strategy of acquisition that is helping in the growth of revenue of the companies and in turn influencing the growth of the market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1

Liquid Biopsy Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2027


Market Highlights

Biopsy involves extracting a sample of tissue and testing it for the presence of diseases especially cancer. Traditional tissue biopsy is a painful technique and also has a high rate of false results. Moreover the technique is costly, time consuming and not applicable for extracting samples such as those close to vital organs such as heart. Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of sophisticated detectors with extremely low detection rates have enabled the early detection of diseases which is the holy grail of cancer.

Other market drivers for the liquid biopsy market are rising rates of cancer, growing investment in research and development, collaborations between companies and public organizations, rise in geriatric population, rising expenditure on health etc. The factors which are inhibiting the growth of the market includes the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. However, not all cancer patients benefit from early detection as some cancer types such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Also the technique is not applicable to all types of cancer as some cancers such as brain cancer and prostate cancer may lie dormant for many years, and thus are either undetectable or detected very late which robs liquid biopsy of its advantages. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Major Players of Global liquid biopsy market:

The major participants of this liquid biopsy companies are: Guardant Health, Inc., Trovagene, Inc., RainDance Technologies, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics, Inivata Ltd., SAGA Diagnostics AB, Exosome Diagnostics and others.

Segmentation:

Global Liquid Biopsy Market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centres and others.

Regional Analysis:

Depending on geographic region, Liquid biopsy market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Liquid biopsy. Europe is the second-largest market for liquid biopsy. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1

Optical Biometry Devices Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2027


Market Highlights

The global optical biometry devices market size accounted for USD 275.0 million in 2018 and is projected to register a CAGR of 5.6% over the forecast period. Optical biometry, also known as ophthalmic biometry, is the current standard for intraocular lens (IOL) power calculations in clinical practice. This is used to measure the anatomical characteristics of the eye. Optical biometry by using partial coherence interferometry (PCI) is more accurate, easy to perform, non-invasive, and comfortable for the patient. Factors characterizing the market growth are worldwide increasing geriatric population, increased efficiency of optical biometry over ultrasound A-scans, growing awareness about eye care, rising older population, and a surge in the number of cataract and refractive surgeries. A data published by the World Health Organization (WHO), globally, approximately 1.3 billion people live with some form of vision impairment at present. On the contrary, lack of skilled personnel and high cost of optical biometry devices are anticipated to hinder the market growth over the forecast period.

Next-generation optical biometry devices reduce the undetected poor fixations by the optical ultrasound biometry devices. Furthermore, these devices are highly efficient and fast, eliminating manual errors from traditional biometry devices. For instance, Pentacam AXL is used with a single measuring operation. It has a comprehensive biometry for intraocular lens (IOL) database and provides a well-targeted screening process for eyes.

Key Players

Few of the leading players in the global optical biometry devices market are Carl Zeiss AG, Bausch & Lomb Incorporated, Haag-Streit AG, NIDEK CO., LTD., Topcon Corporation, Welch Allyn, Inc., Heine Optotechnik GmbH & Co. KG, Tomey Corporation, AMETEK, Inc., Optovue, Incorporated, Leica Microsystems GmbH, and CENTERVUE S.p.A.

Segmentation

The global Optical Biometry Devices Market Size has been segmented into product and end user.

By product, the market has been segmented into swept-source optical coherence tomography (SSOCT)-based biometers, partial coherence interferometry (PCI)-based biometers, and optical low coherence reflectometry (OLCR)-based biometers. The swept-source optical coherence tomography (SSOCT)-based biometers segment held the largest market share in 2018 due to its features such as multiple measurements in a single process, fast data acquisition, and the capability to overcome ocular opacities and superior wavelength. The swept source technology provides clear advantages over the partial coherent interferometry, including the ability to measure the axial length along six different axes and extremely rapid data acquisition.

The partial coherence interferometry-based biometers segment is expected to register the fastest CAGR over the forecast period as optical biometry using partial coherence laser interferometry (PCLI) offers advantages in accuracy and reproducibility of axial length (AL) determination as well as are more comfortable for the patient and the investigator as compared to conventional ultrasonic biometry.

Based on end user, the optical biometry market has been classified into hospitals, ophthalmic clinics, and others. A gradual rise in the number of government and private hospitals in emerging countries such as China and India along with increase in the adoption of optical biometry devices in hospitals is expected to support the dominance the hospital’s segment. In terms of value, the US is holding comparatively larger share (hospitals) of the market; however, decreasing number of hospitals in recent years is limiting the market growth. According to the American Hospital Association (AHA), currently, total number of hospitals in the US are 6,210.

The ophthalmic clinics segment would register comparatively higher CAGR throughout the forecast period owing to increasing density of ophthalmology clinics in developed and developing markets contributing to rising adoption of next generation optical biometry devices.

Regional Segmentation

The global optical biometry devices market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1

Idiopathic Pulmonary Fibrosis Market Size, Product Launch, Major Companies, Revenue Analysis, Till 2027


Market Highlights

It is estimated that the global IPF treatment market is expected to register a CAGR of 12.3% during the forecast period of 2022 to 2027, with a market value of USD 2,237 million in 2022.

IPF is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases. However, the high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment market.

The global idiopathic pulmonary fibrosis market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in September 2022, FibroGen, Inc. announced that the grant of Fast Track designation by US Food and Drug Administration (FDA) for the company’s anti-CTGF antibody, Pamrevlumab, for the treatment of patients with IPF.

Key Players

Some of the key players in the global IPF treatment market are Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La Roche AG, Fibrogen, Inc., Cipla, Merck & Co., Inc., Prometic Life Sciences Inc., and others.

Segmentation

The global Idiopathic Pulmonary Fibrosis Treatment Market Size has been segmented based on treatment.

The market, based on treatment, has been further divided into drug class, oxygen therapy, lung transplant, and others. The drug class segment is likely to hold a major share in the market due to the increasing adoption of the drugs for the treatment of IPF and wider preferability. The oxygen therapy segment is predicted to be the fastest growing due to the increasing inclination of medical professionals towards this therapy for the treatment of IPF.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The IPF treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European IPF treatment market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The IPF treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The IPF treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1

Immunoassay Market Revenue, Trends, Market Share Analysis, and Forecast to 2027


Market Highlights

The global immunoassay market size accounted for USD 18,626.7 million in 2022 and is projected to register a CAGR of 5.9% over the forecast period. Immunoassay is a biochemical test that relies on biochemistry to measure the presence and concentration of an analyte (protein, lipid, nucleic acid, among others) in solution (serum, urine, etc.) by using antibody-antigen reactions. Some of the factors characterizing the market growth are rising R&D expenditure in the healthcare sector, rising prevalence of chronic and infectious diseases, increasing adoption of immunoassay, technological advancements in immunoassay instruments and the introduction of novel automated systems, and surging elderly population across the world. For instance, the World Health Organization (WHO) reported that global elderly population was 841.0 million in 2013, increased to 962.3 million in 2022, which is projected to reach more than 2.0 billion by the end of 2050. In contrast, limitations associated with immunoassay techniques, lack of reimbursement policies in some countries are anticipated to impede the market growth from 2022 to 2027.

Automation provides advantages like better efficiency and optimal usage of labor and space in laboratories. Market vendors are introducing automated laboratory systems, portable assay tests, and point-of-care testing compact. For instance, Thermo Fisher Scientific Inc. launched Thermo Scientific QMS Plazomicin Immunoassay, the complementary diagnostic immunoassays to measure the concentration of a novel therapeutic antibiotic, plazomicin, using the automated clinical chemistry analyzer. Technological developments in the immunoassay instruments and the launch of novel automated systems are nourishing market growth. Tremendous advances in immunoassay formats, immunoanalytical systems, bioanalytical platforms, and complementary technologies have led to various emerging immunochemistry technologies. Automated assays are equipped with robotic workstations while the microtiter plate (MTP) readers are improved extremely in terms of technology, features, and cost-effectiveness.

Key Players

Few of the leading players in the global immunoassay companies are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.p.A.

Segmentation

The global Immunoassay Market has been segmented into product, technology, indication, end user, and region.

By product, the market has been segmented into reagents and kits, analyzers/instruments, software, and services. The reagents and kits segment was the largest value contributor in the global immunoassay market in 2022 due to the rising incidence of chronic and infectious diseases, growing use of reagents and kits along with its repetitive purchase by the users.

On the basis of technology, the market has been divided into radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), enzyme-linked fluorescent assay (ELFA), chemiluminescence immunoassay (CLIA), rapid test, and others. The enzyme-linked immunosorbent assay segment is expected to dominate the market throughout the forecast period owing to its higher adoption as it helps in the detection of food allergies, West Nile virus infection and various diseases, namely, acquired immunodeficiency syndrome (AIDS), Lyme ailments, influenza, and Ebola, etc.

By indication, the global immunoassay market has been categorized into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious diseases, autoimmune diseases, and others.

Based on end user, the market has been classified into hospitals, clinical laboratories, blood banks, pharmaceutical and biotechnology companies, academic and research institutes, and others.

Regional Analysis

The global immunoassay market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On a regional basis, the Americas would showcase supremacy over other regions throughout the forecast period. This is attributed to headquartered major market participants, increasing expenditure on research and development activities, the rising burden of chronic diseases and sophisticated healthcare infrastructure, and growing adoption of immunoassay in the US and Canada. For instance, as per the data published by Pharmaceutical Research and Manufacturers of America (PhRMA), the US pharmaceutical research and development (R&D) expenditure had grown from USD 2 million in 1980 to USD 71.4 million in 2022.

Europe would follow Americas in terms of value over the forecast period due to flourishing pharmaceutical and biotechnology companies, mounting adoption in diagnostic measures, and growing use of chemiluminescent immunoassay in the UK, Germany, and France. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2016, Europe accounted for 21.5% of world pharmaceutical sales, which rose to 22.2% of global pharmaceutical sales in 2022.

The market in Asia-Pacific would register the fastest market growth over next seven years owing to booming medical tourism, rapid developing healthcare infrastructure, increasing geriatric population coupled with the rising burden of chronic diseases, growing awareness about immunoassay tests in the developing countries, such as China, India, Singapore, and Australia. The World Health Organization (WHO) stated that noncommunicable diseases (NCDs), mainly cardiovascular diseases (CVD), chronic respiratory diseases, cancer, and diabetes are top killers in the South-East Asia Region, claiming an estimated 8.5 million lives every year.

The Middle East & Africa are projected to demonstrate a steady growth in the global immunoassay market over the forecast period. In addition, the major market share of the region would be held by the Middle Eastern region due to recent activity from governments in the region approaching investors to expand the private sector in healthcare which continues to be encouraging.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1

Intravascular Catheter Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2027


Market Insights

Market Research Future (MRFR) estimated that the global intravascular catheter market is set to attain a market value of USD 4, 318 million, with a CAGR of 9.3% during the forecast period (2022-2027).

The global intravascular catheter market is driven by some of the various factors, such as the rising rate of hospitalization owing to the growing prevalence of infectious diseases. The increasing number of catheterization laboratories is anticipated to propel the growth of the market.

On the other hand, lack of expertise and advanced medical infrastructure in developing nations is expected to restrain the growth of the global intravascular catheter market. The increasing number of surgeries for the patients under treatment for chronic diseases, rise in demand for invasive surgical procedures by using catheters at ambulatory surgical centres are some of the critical drivers propelling the growth of the global intravascular catheters market.

Inadequate quality assurance, volatile pricing, and limited reimbursement in various developing nations are some the restraining factor in the global market. Increased count of surgeries for treating gastroenterology, cardiovascular, renal, and other diseases is one of the critical pointers driving the global intravascular catheter market.

Market Players

The global intravascular catheter market is driven by various leading players with their product offerings and services. Some of these major players include Cook Medical, Medtronic Inc, Johnson & Johnson, C.R. Bard, Coloplast, Getinge AB, Terumo Corporation, Boston Scientific Corporation, Edwards Life Sciences Corporation, Terumo Corporation, McKesson Medical Surgical Inc, and Smiths Medical. Product developers are major adopting latest technologies such as connected devices and smart materials to build efficient and reliable products.

Market Segmentation

The global Intravascular Catheter Market Share is broadly bifurcated on the basis of product, application, and end-user.

Based on the product, the global market is diversified into integrated/closed PIVC catheters and short PIVC catheters.

The application segment is divided into cancer, renal disease, infectious diseases, gastrointestinal diseases, and other diseases.

The global end-user segment is split into hospitals, clinics, ambulatory surgical centers, home care, and others

Regional Insights

The global intravascular catheter market is dominated by the Americas, owing to a rise in per capita income, heavy adoption, and increased healthcare expenditure. Growing occurrences of hospital-acquired infection and the present of advanced healthcare facilities jointly foster the market growth in the North America region. Favorable reimbursement facilities related to intravascular catheters further motivate the market growth in the region.

The European intravascular catheter market is anticipated to grow exponentially while maintaining its dominance in the second position. The market is attributed to the existence of leading industry giants and the rising prevalence of deadly diseases.

Asia Pacific region is likely to grow rapidly owing to the massive patient population suffering from chronic diseases and government initiatives for healthcare reforms.

Moreover, the Rest of the World, specifically the Middle East & Africa, is anticipated to hold least share of the global intravascular catheter market. Low per capita incomes and volatile economic reforms are some of the factors restraining the growth of this regional market.

Recent Updates

The U.S. FDA called out two new guidance for labeling and testing of cardiac catheterization lab devices. Under the newly issued guidance, the wires, intravascular catheters, and delivery systems with lubricious coatings will be addressed with labeling considerations specially used for vasculature. The new guidance is believed to improve the reliability of coating-related information across these products portfolios with an assurance of safety on the use of these devices in the clinical setting.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1

Cancer Registry Software Market Revenue, Trends, Market Share Analysis, and Forecast to 2027


Market Insights

Cancer registry software is a programmed tool of a directory that creates and maintains end-to-end reporting of cancer incidences. It is majorly used to get an overview of certain cases while investigating cancer and its causes. According to Market Research Future, the global cancer registry software market reached $56.4 Million in 2022 and is predicted to attain a CAGR of 10.7% during the forecast period, 2022-2027

Extraordinary breakthroughs and penetrations of science and technology are evolving radically and restructuring the practice of medicine. Aging population, growing middle spending abilities on healthcare, the burden of chronic disease is transforming the patient needs. However, these factors are stimulating new demands dedicated to innovation and access to advanced tools that deliver reliable patient data and comprehensive report of every stage in treatment.

Novel technologies such as predictive modeling for medical procedures are set to flourish owing to growing investment in R&D activities in the field of clinical and molecular data. Growing trend of using data analytics to create reference case study for futuristic clinical operations is likely to propel the global cancer registry software market.

Major Players

Industry leaders are keenly focusing on the development of convenient and accessible solutions for handling critical data related to cancer. Some of the leading players contributing with their product and services include McKesson Corporation, Electronic Registry Systems, Inc., IBM, C/Net Solutions, Himagine Solutions Inc, Rocky Mountain Cancer Data Systems, Ordinal Data Inc, Conduent Inc, Elekta AB (PUB), and Onco, Inc.

Market Segmentation

The global Cancer Registry Software Market is broadly segmented based on the factor such as type, deployment model, database, functionality, and end-user.

The type segment is bifurcated into standalone software and integrated software.

Based on the deployment model, the global cancer registry software market is divided into on-premise and cloud-based.

Similarly, the database type segment is classified into public and commercial.

On the basis of functionality, the global cancer registry software market is segmented into product outcome evaluation, patient care management, medical research, clinical studies, and reporting to federal regulations.

Moreover, the end-user segment is diversified into hospitals, government organizations, medical practitioners, pharmaceutical, research centers, medical device companies, and biotechnology.

Regional Analysis

Geographically, the Americas is expected to influence the global cancer registry software market owing to the growing focus on high-tech product development, growing investment for R&D in region. As per National Cancer Institute, approximately 1,735,350 new cases of cancer were registered in the US, in 2022.

Europe ranks second after the Americas owing to funding availability and existence of robust research and academic institutes in the region. The European cancer registry software market is anticipated to register a considerable growth during the forecast period.

Moreover, emerging pharmaceutical industry due to low manpower cost and favorable trade conditions in developing markets such as India and China are foreseen to speed up the growth of cancer registry software market in Asia Pacific. A growing number of cancer patients in these regions in contrast to the escalating population makes it mandatory to keep a track on every cancer patient and their diagnostic data.

The Middle East & Africa has the least contribution in the global cancer registry software market and is anticipated to see a moderate growth owing to rising government initiatives for healthcare sectors.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1

Immunoprecipitation Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2027


Market Analysis

The global immunoprecipitation market is predicted to touch USD 562 million at a 5.2% CAGR over the forecast period (2022-2027), states the new Market Research Future (MRFR) report. Immunoprecipitation (IP), simply put, is a technique to precipitate a protein antigen out of a solution utilizing an antibody which specifically binds to that specific protein. The process can be used for isolating and concentrating a specific protein from a sample having thousands of various proteins. The IP technique help researchers in identifying the proteins activation status, determining protein modifications that are post-translational, measuring a given protein’s molecular weight, and capturing protein-binding molecules in both the study of protein-nucleic and protein-protein interactions.

Various factors are propelling the immunoprecipitation market growth. These factors, as per the new MRFR report, include increasing number of research activities in life science, growing need for identifying antigens related to autoimmune diseases, and increasing investments by industries and governments. Additional factors pushing market report include growing awareness regarding personalized therapeutics, rising biotechnology research, a growing number of immunoprecipitation assays to purify and isolate antigens, and repeat purchase of kits.

On the flip side, the availability of alternative protein purification technologies may hamper the immunoprecipitation market growth over the forecast period.

Key Players

Leading players profiled in the immunoprecipitation market report include Geno Technology Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals Inc., Takara Bio Inc., BioLegend, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, and Abcam plc, GenScript. Various strategies have been adopted by key players for capturing the competitive market such as partnerships, collaborations, mergers and acquisitions, research and development activities, and more.

April 2022: EpiCypher has signed an agreement with Thermo Fisher Scientific to offer co-exclusive usage of SNAP ChiP (sample normalization and antibody profiling for chromatin immunoprecipitation) technology that is specific for histone PTMS.

Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the Immunoprecipitation Market Size report on the basis of product, type, and end user.

Based on type, the immunoprecipitation market is segmented into RNA immunoprecipitation, chromatin immunoprecipitation, co-immunoprecipitation, and individual immunoprecipitation. Of these, the individual immunoprecipitation segment will have the largest share in the market over the forecast period. The individual immunoprecipitation is widely used to study protein-protein interactions for detecting the presence of antigens and determining its relative quantity that is driving its use in different research studies.

Based on product, the immunoprecipitation market is segmented into reagent, kit, and others. The reagent segment is again segmented into beads and antibodies. Antibodies are again segmented into primary as well as secondary. Beads are again segmented into buffers, magnetic beads, and agarose beads. Of these, the agarose beads segment will dominate the market over the forecast period.

Based on end user, the immunoprecipitation market is segmented into contract research organizations, academic and research institutes, pharmaceutical and biotechnology companies, and others. Of these, the pharmaceutical and biotechnology companies segment will lead the market over the forecast period chiefly due to the growing demand for protein-based drugs.

Regional Analysis

By region, the immunoprecipitation market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. Factors aiding growth in the region include the presence of several market players, increasing research activities, and a well-developed healthcare sector in the region.

The immunoprecipitation market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly due to the accessibility of funds for research.

The immunoprecipitation market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include growing awareness regarding personalized therapeutics, growing biotechnology research in the region, and growing investment from governments.

The immunoprecipitation market in the Middle East and Africa is predicted to have a small share in the market over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0

Vascular Closure Devices Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2027

Vascular Closure Devices Market – Overview

The surge in diagnostic angiography procedures is a key factor motivating the market of vascular closure devices. Reports that review the medical device industry have been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities. The vascular closure devices market is likely to capture a CAGR of 6.8% in the upcoming period.

The increased rates of interventional procedures are boosting the market for vascular closure devices market. The escalated level of approvals being given to vascular closure devices is expected to boost the progress of the market in the coming period. Moreover, the improved efficiency rate of vascular closure devices is anticipated to encourage the market in the coming period.

Key Players:

The competitors adding substantially to the vascular closure devices market are Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Abbott Laboratories, Morris Innovative, Inc., Merit Medical Systems, Inc., Medtronic plc, Vasorum Ltd., Vascular Closure Systems, Inc., Essential Medical, Inc., TZ Medical, Inc., Transluminal Technologies LLC, Vivasure Medical Ltd., among others.

Segmental Analysis

The segmentation of the Vascular Closure Devices Market is carried out on the basis of access, product type, procedures, application, and end user. By product type, the vascular closure devices market is segmented into active vascular closure devices, passive vascular closure devices, and external hemostatic devices. On the basis of access, the vascular closure devices market is segmented into radial access and femoral access. By procedures, the vascular closure devices market is segmented into interventional radiology/vascular surgery and interventional cardiology. On the basis of application, the vascular closure devices market is segmented into therapeutic intervention and diagnostic intervention. Based on the end user, the vascular closure devices market is segmented into specialty centers, hospitals & clinics, ambulatory surgery centers, and others. Based on the region, the vascular closure devices market is segmented into Europe, Asia Pacific, the Americas, and the Middle East and Africa.

Competitive Analysis

The incidence of popular products and brands is determining the expansion of the market to a significant extent. The strategic success features are also constructively impacting the evolution of the market. The reinforcement of the distribution channels in the market is presumed to augment the saturation of the products. In the approaching years, market viability will increasingly improve as modernization, and product advances encourage positive changes. The industry cost make-up is also likely to modify with time. The market conditions are extremely dependent on the factors that are influencing the prospects and the challenges that are prevailing in the market. The players in the market are making certain that the product and services being offered in the market are supporting the preferences of their user base favorably. The innovative trends emerging in the market are expected to set the foundation for vigorous development in the forthcoming period. The market size is also anticipated to increase significantly in the approaching years. Also, the development of technology has increased momentum, guiding to improved market growth.

Detailed Regional Analysis

The regional evaluation of the vascular closure devices market projects that the Americas region dominated the vascular closure devices market due to the factors such as increasing awareness about the vascular closure devices among medical professionals along with the upsurge in research funding. The European region is anticipated to control the next largest portion of the vascular closure devices market due to the many initiatives by private and public organizations that are anticipated to lift the development of the vascular closure devices market. The Asia Pacific region was likely to be the fastest developing region for the vascular closure devices market. This can be attributed to the technological developments that are resultant of the developments in cost-effective vascular closure devices contributing to the high acceptance rate for the devices in the Asia Pacific region. The Middle East and Africa region holds the minimum share of the global vascular closure devices market owing to the incidence of economically varied countries, and fewer initiatives being initiated by the government.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0

Dental Lasers Market Revenue, Trends, Market Share Analysis, and Forecast to 2027


Market Overview:

Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries. These lasers prevent the need for surgical instruments like coherent light beams, coherent light beams, and handpieces. Dental lasers also offer benefits like less contamination, less trauma, and less bleeding and are being accepted across the globe due to their ability like short healing time, lower light exposure, portability, and does not require anesthesia. The global dental lasers market, as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period (2017-2023).

The increasing number of dental disorders among the global population and surging awareness associated with oral hygiene is considered the key growth stimulants of the dental lasers market. Innovations made in treatment technologies and dental disorders diagnostics are estimated to offer the market a thrust. Advantages like reduced need for sutures and minimized bleeding are likely to encourage the market growth across the globe.

The rising spending on cosmetic dentistry is predicted to trigger the demand for dental laser equipment. Cosmetic dentistry is experiencing significant growth, especially in developed countries like Europe and North America owing to the high disposable income. As the aging population is prone to tooth decay and gum diseases, the surge in geriatric population suffering from dental lasers comparisons will further encourage the market growth in the foreseeable future.

On the contrary, dental lasers are expensive compared to their substitutes like dental drills, which is estimated to deter the market growth.

Competitive Dashboard:

The top players operating in the Dental Lasers Market include Biolase, Inc., AMD Lasers, Convergent Dental, Inc., Cao Group, Inc., Fotona D.D., Danaher Corporation- Kavo Dental GmbH, Millennium Dental Technologies, Inc., Ivoclar Vivadent AG, Syneron Dental Lasers-Syneron Medical Ltd., Sirona Dental Systems, Inc., Zolar Technology & MFG. Co. Inc., and The Yoshida Dental MFG. Co., Ltd.

Global Dental Lasers Market: Segmental Analysis

The dental lasers market has been segmented on the basis of application, product, and end users.

By product, the dental lasers market is segmented into all tissue dental lasers and soft tissue dental lasers. Of these, the soft tissue dental lasers segment will expand at a significant pace due to rising incidences of soft tissue disorders like gingivitis periodontal disorders.

The application segment comprises oral surgery, endodontic treatment, peri-implantitis, implantology, periodontics, and others. Of these, the periodontics segment will gain prominence due to the surging number of periodontics and increasing the spending power of the consumers.

The end users’ segment is segmented into ambulatory surgical units, hospitals & clinics, and academic & research organizations. Of these, the hospitals & clinics segment will gain prominence owing to the high availability of specialized physicians. Increased preferences for diagnosis and treatment at the clinics will further augment the market growth in the segment.

Regional Frontiers:

Geographically, the dental lasers market spans across Europe, Asia Pacific, North America, and the Middle East & Africa.

Considering the global scenario, North America is estimated to acquire the lion’s share and dominate the market, mainly due to the surging cases of dental diseases and increased expenditure on healthcare. As per a study by the National Institute of Dental & Craniofacial Research, around 92% of the adults are predicted to suffer from dental diseases. The existence of developed countries like Canada and the U.S. are further likely to influence the market growth in the region.

Europe bags the second spot with 30%-35% of the total market share. The growth of the regional market can be ascribed to the high dental healthcare expenditure, surging penetration of the market players, and increased government support for the dental sector.

The Asia Pacific is estimated to expand at a rapid pace due to the surging geriatric population, increased preferences for minimally invasive surgeries, and soaring awareness regarding dental lasers. The rapid boom in the dental industry has made the region lucrative for market expansion and development. The rising awareness regarding the guaranteed treatment of dental lasers has further encouraged the market growth. In this region, India is likely to experience significant growth due to surging number of dental diseases caused due to high consumption of alcohol, tobacco, and other products. Surging demand for cosmetic dentistry, coupled with the rising medical tourism will propel the market growth in the APAC.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Show more
0
1